Home/Investors/HongShan

HongShan

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

3

Top Stage

commercial

Investment Focus

Surgery Immunology Inflammation

Portfolio Companies

Company	Stage	Valuation	Focus
Edge Medical	commercial	—	Surgery
QuantX Biosciences	Pre-clinical	—	Immunology, Inflammation

Frequent Co-Investors

OrbiMed2 shared Temasek Holdings1 shared Boyu Capital1 shared 3H Health1 shared LYFE Capital1 shared China State-Owned Enterprise Mixed Ownership Reform Fund1 shared Sanofi Ventures1 shared Creacion Ventures1 shared